Sam Levine

Sam Levine is an experienced professional with extensive background in leadership roles across various industries. Currently serving as Director at Mindbloom since 2021, Sam contributes to the company's position as the largest provider of psychedelic therapy globally. In addition to this role, Sam has been a Director at PAX Labs, Inc. since 2019, focusing on technology in the cannabis sector. Previously, as Head of Strategy and Operations at Seso Inc. from 2021 to 2024, Sam supported agricultural workforce solutions. Sam's advisory experience at Redesign Health from 2018 to 2021 included impactful contributions to healthcare innovation. Additionally, as a co-founder of Candid™ from 2017 to 2021, Sam helped transform oral health delivery through technology. Sam's earlier career includes investment roles at Eton Park and The Blackstone Group, as well as experience at the Federal Reserve Board. Educational credentials include an MSc in Financial Economics from the University of Oxford and dual Bachelor's degrees in Systems Science and Engineering and Finance from the University of Pennsylvania.